Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesis.
BACKGROUND: Increased intra-hepatic resistance to portal blood flow is the primary factor leading to portal hypertension in cirrhosis. Up-regulated expression of cyclooxygenase-2 (COX-2) in the cirrhotic liver might be a potential target to ameliorate portal hypertension. OBJECTIVE: To verify the ef...
Main Authors: | Jin-Hang Gao, Shi-Lei Wen, Wen-Juan Yang, Yao-Yao Lu, Huan Tong, Zhi-Yin Huang, Zhang-Xu Liu, Cheng-Wei Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3724827?pdf=render |
Similar Items
-
Cirrhotic Endothelial Progenitor Cells Enhance Liver Angiogenesis and Fibrosis and Aggravate Portal Hypertension in Bile Duct-Ligated Cirrhotic Rats
by: Dinesh Mani Tripathi, et al.
Published: (2020-06-01) -
Retrospective Study of Transjugular Intrahepatic Portosystemic Shunt Placement for Cirrhotic Portal Hypertension
by: Sara Santos, et al.
Published: (2020-06-01) -
Advances in transjugular intrahepatic portosystemic shunt and its application in treatment of cirrhotic portal hypertension
by: XIAO Jiangqiang, et al.
Published: (2016-02-01) -
Non-cirrhotic portal fibrosis
by: Venkatesan Mukta, et al.
Published: (2014-01-01) -
Emricasan Ameliorates Portal Hypertension and Liver Fibrosis in Cirrhotic Rats Through a Hepatocyte‐Mediated Paracrine Mechanism
by: Jordi Gracia‐Sancho, et al.
Published: (2019-07-01)